| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.66484951 |
| From this deletion analysis , we determined that TRAF 2 , TRAF 5 , and TRAF 6 interact with RANK at its C terminal 85 amino acid tail ; the binding affinity appeared to be in the order of TRAF 2 > TRAF 5 > TRAF 6 . 0.66484951^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| When battery operated CDC miniature incandescent and black light traps ( with and without light bulbs ) were operated with and without CO 2 , the rank of trap effectiveness for total numbers of female Culicoides variipennis caught was : black light plus CO 2 ; CO 2 baited trap without light bulb ; black light without CO 2 ; incandescent light plus CO 2 and incandescent light without CO 2 . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Juvenile turkeys had higher rank abundance values of L . smithi than adults , whereas no differences were found among trap sites or between sexes . ^^^ No differences in rank abundances of H . meleagridis were found among trap sites , host age , or host sex variables . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| We have previously shown that the cytoplasmic domain of receptor activator of NF kappaB ( RANK ) interacts with TRAF 2 , TRAF 5 , and TRAF 6 and that its overexpression activates NF kappaB and JNK pathways . ^^^ Through a detailed mutational analysis of the cytoplasmic domain of RANK , we demonstrate that TRAF 2 and TRAF 5 bind to consensus TRAF binding motifs located in the C terminus at positions 565 568 and 606 611 , respectively . ^^^ Furthermore , transfection experiments with RANK and its deletion mutants in human embryonic 293 cells revealed that the TRAF 6 binding region ( 340 358 ) , but not the TRAF 2 or TRAF 5 binding region , is necessary and sufficient for RANK induced NF kappaB activation . ^^^ However , RANK mediated JNK activation required a distal portion ( 427 603 ) of RANK containing the TRAF 2 binding domain . ^^^ Thus , our results indicate that RANK interacts with various TRAFs through distinct motifs and activates NF kappaB via a novel TRAF 6 interaction motif , which then activates NIK , thus leading to NF kappaB activation , whereas RANK most likely activates JNK through a TRAF 2 interacting region in RANK . . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Levels of NTBI , which is normally not found in plasma , increased rapidly during conditioning therapy ( p < . 02 in both groups ) and correlated inversely with TRAP ( weighted intraindividual Spearman rank correlation coefficient for both groups : NTBI and TRAP : r = . 59 , p < . 001 ) and PUFA ( in the radiochemotherapy group : r = . 67 , p < . 001 ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| The IC ( 50 ) for three known oxyanion inhibitors of TRAP / PAP was similar for bone and nTRAP with the same rank order of potency ( molybdate > tungstate > phosphate ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| In the presence of macrophage colony stimulating factor ( M CSF ) ( 20 ng / ml ) and receptor activator of NF kappaB ligand ( RANK L ) ( 50 ng / ml ) , TGF beta 1 ( 0 . 01 5 ng / ml ) dose dependently stimulated ( by up to 120 fold ) osteoclast formation ( assessed by the presence of tartrate resistant acid phosphatase ( TRAP ) positive multinucleated cells and expression of calcitonin and vitronectin receptors ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| RANK and RANKL expression were analyzed using specific immunohistochemistry , and tartrate resistant acid phosphatase ( TRAP ) staining was performed . ^^^ In areas where RANK positive cells were abundant , TRAP positive , multinucleated osteoclast like cells were also present at sites of focal bone erosion , suggesting differentiation of synovially derived RANK positive osteoclast precursor cells into osteoclasts . ^^^ CONCLUSION : Cells expressing RANK increased in abundance with the progression of arthritis in evolving CIA , and sites of RANK expressing cells correlated with sites of TRAP positive , multinucleated osteoclast like cells as well as with sites of RANKL expression . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| In contrast , high Ca treatment at the later stage of osteoclastogenesis ( the last 2 days of culture ) stimulated the formation of TRAP ( + ) MNCs , increased RANKL and RANK mRNA expressions and decreased OPG mRNA . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| In addition , we aimed to determine the types of cells expressing these factors in these tissues and to demonstrate the expression of the osteoclastic markers , RANK and tartrate resistant acid phosphatase ( TRAP ) , in periodontitis . ^^^ Many leukocytes expressing RANK mRNA and TRAP were observed in periodontitis tissues . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| We found that the majority of the ectopically expressed RANK and substantial portion of endogenous TRAF 2 and TRAF 6 were detected in the low density raft fractions . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Gene levels of RANK , RANKL , TNFalpha , IL 1beta , and cathepsin K ( CK ) were quantified by real time RT PCR , and TRAP staining of pouch membrane was used to evaluate osteoclastogenesis . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| RAW 264 . 7 cells plated at 10 ( 4 ) cells / cm ( 2 ) and cultured for 4 days in the presence of RANKL represent the optimal culture conditions for osteoclast differentiation , with an up regulation of all parameters related to bone resorption : tartrate resistant acid phosphatase ( TRAP ) , calcitonin receptor ( CTR ) , RANK , cathepsin K , matrix metalloproteinase ( MMP ) 9 mRNA expressions . ^^^ RANKL and OPG biological effects vary according to the differentiation state of the cells : in undifferentiated RAW 264 . 7 cells , TRAP expression was decreased by OPG and RANKL , RANK expression was inhibited by OPG , while MMP 9 and cathepsin K mRNA expressions were not modulated . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| When overexpressed , PIAS 3 inhibits NF kappaB dependent transcription induced by treatment with tumor necrosis factor alpha ( TNF alpha ) or interleukin 1beta or by overexpression of TNF family receptors such as RANK , TNFR 1 , and CD 30 or signal transducers of TNF receptor associated factors ( TRAFs ) , including TRAF 2 , TRAF 5 , and TRAF 6 . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| SH SY5Y showed the lowest OPG to RANKL ratio and promoted osteoclastic differentiation of FLG29 . 1 and peripheral mononuclear cells , inducing expression of the osteoclast markers RANK , c src , c fos , cathepsin K and TRAP . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| First , reverse transcriptase polymerase chain reactions ( RT PCR ) were carried out to detect the mRNA encoding receptor activator of NF kappaB ( RANK ) , RANK ligand ( RANKL ) , osteoprotegerin ( OPG ) , tumour necrosis factor alpha ( TNF alpha ) , interleukin ( IL ) 1beta , IL 6 and the osteoclast markers tartrate resistant acid phosphatase ( TRAP ) and cathepsin K . ^^^ In real time PCR , the expression levels of TNF alpha , IL 1beta , IL 6 , RANKL , TRAP and cathepsin K mRNA increased , whereas the expression levels of RANK and OPG were unchanged and decreased respectively . ^^^ Quantitative real time PCR showed that TNF alpha , RANK and TRAP mRNA expression did not change significantly with time , and that IL 1beta and cathepsin K changed slightly compared with those in the synovium . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| We investigated time course changes in the expression of receptor activator of nuclear factor kappaB ( RANK ) , its ligand ( RANKL ) , osteoprotegerin ( OPG ) , bone type alkaline phosphatase ( BAP ) , and tartrate resistant acid phosphatase ( TRAP ) in ovariectomized ( OVX ) rats . ^^^ The expression profiles of TRAP , RANK , and RANKL proteins in the coccyx specimens were similar to the pattern of serum TRAP activity , while the profiles of the BAP and OPG proteins were similar to the pattern of serum BAP activity in OVX rats . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| We found that unlike RANK null mice , which completely lack osteoclasts , IKK alpha ( / ) mice did possess normal numbers of TRAP ( + ) osteoclasts . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| The expression of genes involved in osteoclast differentiation and activation was evaluated , i . e . c fms , RANK , c src , c fos , cathepsin K ( CATK ) , TRAP , and calcitonin R ( CTR ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| RT PCR was used to measure the expression of RANK , matrix metalloproteinase 9 , TRAF 6 , TRAP , integrin alpha 5 , integrin beta 3 , cathepsin K , and carbonic anhydrase 2 ( CA 2 ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| The increased osteoclast motility and activation in response to SDF 1alpha was associated with an increase in the expression of a number of osteoclast activation related genes , including RANKL , RANK , TRAP , MMP 9 , CA 2 , and Cathepsin K . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| INTRODUCTION : TNF receptor associated factor 2 ( TRAF 2 ) is a signal transducer for RANK and for two TNF receptor isotypes , TNFR 1 and TNFR 2 . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| POS 1 cells showed no mineralization capacity and exhibited an undifferentiated phenotype , expressing both osteoblastic and unexpected osteoclastic markers ( TRAP , cathepsin K and RANK ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Our findings indicate that : ( 1 ) EM reduced UHMWPE induced tissue inflammation , including the diminished pouch membrane thickness , reduced inflammatory cellular infiltration , and lowered IL 1beta and TNF alpha expression ( mRNA and protein ) ; ( 2 ) EM inhibited UHMWPE induced osteoclastogenesis , with reduced gene activation of RANK , RANKL , and CPK , and diminished RANKL expression in UHMWPE stimulated pouches , and ( 3 ) EM markedly reduced the number of TRAP ( + ) cells in pouch tissues , and protected against bone collagen depletion . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Furthermore , receptor activator of nuclear factor kappaB ( RANK ) induced the recruitment of tumor necrosis factor ( TNF ) associated factors 2 and 6 ( TRAF 2 and 6 , respectively ) to the cytoplasmic tail of RANKL with activated IkappaB kinase and IkappaB phosphorylation , while D PDMP treatment inhibited RANKL and induced IkappaB phosphorylation , and that inhibition was recovered by LacCer . ^^^ In addition , RANK , TRAF 2 , TRAF 6 , and LacCer were found localized in lipid rafts on the cell surfaces . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Finally , the presence of apigenin inhibited osteoclast differentiation from the RAW 264 . 7 cell line by reducing receptor activator of nuclear factor kappa ligand ( RANKL ) induced expression of tartrate resistant acid phosphatase ( TRAP ) , RANK , and calcitonin receptor but not CCR 1 , resulting in the inhibition of multinucleated osteoclast formation . ^^^ Similarly , apigenin inhibited expression of the osteoclast differentiation markers TRAP , RANK , and c Fms in osteoclast precursor cells obtained from mouse bone marrow following treatment with RANKL and macrophage colony stimulating factor ( MCSF ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| In RANK ( + / + ) mice subjected to UHMWPE stimulation , a large number of TRAP ( + ) cells were found on the implanted bone surface , where active osteoclastic bone resorption was observed . ^^^ No TRAP ( + ) cells were found in UHMWPE containing pouch tissues of RANK ( / ) mice . ^^^ Consistent with the lack of osteoclastic activity shown by TRAP staining , no significant UHMWPE particle induced bone resorption was found in RANK ( / ) mice . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Signaling by TRANCE R appears to be dependent on TNF receptor associated factor 2 ( TRAF 2 ) , since JNK induction is impaired in cells from transgenic mice overexpressing a dominant negative TRAF 2 protein . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| Coimmunoprecipitation experiments suggested potential interactions between the cytoplasmic tail of TRANCE R with TRAF 1 , TRAF 2 , TRAF 3 , TRAF 5 , and TRAF 6 . ^^^ Dominant negative forms of TRAF 2 , TRAF 5 , and TRAF 6 and an endogenous inhibitor of TRAF 2 , TRAF interacting protein ( TRIP ) , substantially inhibited TRANCE R mediated NF kappaB activation , suggesting a role of TRAFs in regulating DC and osteoclast function . ^^^ Analysis of TRANCE R deletion mutants suggested that the TRAF 2 and TRAF 5 interaction sites were restricted to the C terminal 93 amino acids ( C region ) . ^^^ |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q9Y6Q6 and Q12933 |
Pubmed |
SVM Score :0.0 |
| NA |
|